Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 896.00
-1.65 (-0.18%)
Jul 14, 2026, 3:30 PM IST
Granules India Market Cap
Granules India has a market cap or net worth of 221.77 billion as of July 14, 2026. Its market cap has increased by 83.82% in one year.
Market Cap
221.77B
Enterprise Value
227.40B
Revenue
53.66B
Ranking
n/a
PE Ratio
37.27
Stock Price
896.00
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 221.77B, an increase of 135,370.82%. That is a compound annual growth rate of 36.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 221.77B | 52.68% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 418.20B |
| Gland Pharma | 408.50B |
| Emcure Pharmaceuticals | 343.99B |
| Wockhardt | 294.22B |
| Piramal Pharma | 235.12B |
| Eris Lifesciences | 198.32B |
| NATCO Pharma | 176.26B |
| Cohance Lifesciences | 172.88B |